 | • レポートコード：MRC2-11QY04654 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小分子APIのグローバル市場について調査・分析したレポートです。種類別（合成/化学API、生物学的API）市場規模、用途別（心血管、腫瘍学、糖尿病、免疫障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小分子APIの競争状況、市場シェア ・世界の小分子API市場：種類別市場規模 2015年-2020年（合成/化学API、生物学的API） ・世界の小分子API市場：種類別市場規模予測 2021年-2026年（合成/化学API、生物学的API） ・世界の小分子API市場：用途別市場規模 2015年-2020年（心血管、腫瘍学、糖尿病、免疫障害、その他） ・世界の小分子API市場：用途別市場規模予測 2021年-2026年（心血管、腫瘍学、糖尿病、免疫障害、その他） ・北米の小分子API市場分析：米国、カナダ ・ヨーロッパの小分子API市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小分子API市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小分子API市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小分子API市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Albemarle Corporation、Allergan Plc.、Aurobindo Pharma、Cambrex Corporation、Dr. Reddy’s Laboratories Ltd.、Glaxosmithkline Plc.、Lonza、Merck Sharp & Dohme Corp.、Mylan N.V.、Novartis AG、Pfizer Inc.、Siegfried AG、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A small molecule is a low molecular weight (< 900 daltons) organic compound that may regulate a biological process, with a size on the order of 1 nm. Most drugs are small molecules. Larger structures such as nucleic acids and proteins, and many polysaccharides are not small molecules, although their constituent monomers (ribo- or deoxyribonucleotides, amino acids, and monosaccharides, respectively) are often considered small molecules. Small molecules may be used as research tools to probe biological function as well as leads in the development of new therapeutic agents. Some can inhibit a specific function of a protein or disrupt protein–protein interactions. Globally North America is the largest market for small molecule API. Europe is the second-largest market for small molecule API. Furthermore Asia pacific market is expected to be the fastest growing market for small molecule API. Market Analysis and Insights: Global Small Molecular API Market The global Small Molecular API market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Molecular API Scope and Market Size Small Molecular API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecular API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study Albemarle Corporation Allergan Plc. Aurobindo Pharma Cambrex Corporation Dr. Reddy’s Laboratories Ltd. Glaxosmithkline Plc. Lonza Merck Sharp & Dohme Corp. Mylan N.V. Novartis AG Pfizer Inc. Siegfried AG Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Market segment by Type, the product can be split into Synthetic/Chemical API Biological API Market segment by Application, split into Cardiovascular Oncology Diabetes Immunological Disorders Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India
レポート目次1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Molecular API Revenue
1.4 Market by Type
1.4.1 Global Small Molecular API Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthetic/Chemical API
1.4.3 Biological API
1.5 Market by Application
1.5.1 Global Small Molecular API Market Share by Application: 2020 VS 2026
1.5.2 Cardiovascular
1.5.3 Oncology
1.5.4 Diabetes
1.5.5 Immunological Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Small Molecular API Market Perspective (2015-2026)
2.2 Global Small Molecular API Growth Trends by Regions
2.2.1 Small Molecular API Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Molecular API Historic Market Share by Regions (2015-2020)
2.2.3 Small Molecular API Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Small Molecular API Market Growth Strategy
2.3.6 Primary Interviews with Key Small Molecular API Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Small Molecular API Players by Market Size
3.1.1 Global Top Small Molecular API Players by Revenue (2015-2020)
3.1.2 Global Small Molecular API Revenue Market Share by Players (2015-2020)
3.1.3 Global Small Molecular API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Molecular API Market Concentration Ratio
3.2.1 Global Small Molecular API Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Small Molecular API Revenue in 2019
3.3 Small Molecular API Key Players Head office and Area Served
3.4 Key Players Small Molecular API Product Solution and Service
3.5 Date of Enter into Small Molecular API Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Small Molecular API Historic Market Size by Type (2015-2020)
4.2 Global Small Molecular API Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Small Molecular API Market Size by Application (2015-2020)
5.2 Global Small Molecular API Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Small Molecular API Market Size (2015-2020)
6.2 Small Molecular API Key Players in North America (2019-2020)
6.3 North America Small Molecular API Market Size by Type (2015-2020)
6.4 North America Small Molecular API Market Size by Application (2015-2020)
7 Europe
7.1 Europe Small Molecular API Market Size (2015-2020)
7.2 Small Molecular API Key Players in Europe (2019-2020)
7.3 Europe Small Molecular API Market Size by Type (2015-2020)
7.4 Europe Small Molecular API Market Size by Application (2015-2020)
8 China
8.1 China Small Molecular API Market Size (2015-2020)
8.2 Small Molecular API Key Players in China (2019-2020)
8.3 China Small Molecular API Market Size by Type (2015-2020)
8.4 China Small Molecular API Market Size by Application (2015-2020)
9 Japan
9.1 Japan Small Molecular API Market Size (2015-2020)
9.2 Small Molecular API Key Players in Japan (2019-2020)
9.3 Japan Small Molecular API Market Size by Type (2015-2020)
9.4 Japan Small Molecular API Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Small Molecular API Market Size (2015-2020)
10.2 Small Molecular API Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Molecular API Market Size by Type (2015-2020)
10.4 Southeast Asia Small Molecular API Market Size by Application (2015-2020)
11 India
11.1 India Small Molecular API Market Size (2015-2020)
11.2 Small Molecular API Key Players in India (2019-2020)
11.3 India Small Molecular API Market Size by Type (2015-2020)
11.4 India Small Molecular API Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Small Molecular API Market Size (2015-2020)
12.2 Small Molecular API Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Molecular API Market Size by Type (2015-2020)
12.4 Central & South America Small Molecular API Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Albemarle Corporation
13.1.1 Albemarle Corporation Company Details
13.1.2 Albemarle Corporation Business Overview
13.1.3 Albemarle Corporation Small Molecular API Introduction
13.1.4 Albemarle Corporation Revenue in Small Molecular API Business (2015-2020))
13.1.5 Albemarle Corporation Recent Development
13.2 Allergan Plc.
13.2.1 Allergan Plc. Company Details
13.2.2 Allergan Plc. Business Overview
13.2.3 Allergan Plc. Small Molecular API Introduction
13.2.4 Allergan Plc. Revenue in Small Molecular API Business (2015-2020)
13.2.5 Allergan Plc. Recent Development
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Details
13.3.2 Aurobindo Pharma Business Overview
13.3.3 Aurobindo Pharma Small Molecular API Introduction
13.3.4 Aurobindo Pharma Revenue in Small Molecular API Business (2015-2020)
13.3.5 Aurobindo Pharma Recent Development
13.4 Cambrex Corporation
13.4.1 Cambrex Corporation Company Details
13.4.2 Cambrex Corporation Business Overview
13.4.3 Cambrex Corporation Small Molecular API Introduction
13.4.4 Cambrex Corporation Revenue in Small Molecular API Business (2015-2020)
13.4.5 Cambrex Corporation Recent Development
13.5 Dr. Reddy’s Laboratories Ltd.
13.5.1 Dr. Reddy’s Laboratories Ltd. Company Details
13.5.2 Dr. Reddy’s Laboratories Ltd. Business Overview
13.5.3 Dr. Reddy’s Laboratories Ltd. Small Molecular API Introduction
13.5.4 Dr. Reddy’s Laboratories Ltd. Revenue in Small Molecular API Business (2015-2020)
13.5.5 Dr. Reddy’s Laboratories Ltd. Recent Development
13.6 Glaxosmithkline Plc.
13.6.1 Glaxosmithkline Plc. Company Details
13.6.2 Glaxosmithkline Plc. Business Overview
13.6.3 Glaxosmithkline Plc. Small Molecular API Introduction
13.6.4 Glaxosmithkline Plc. Revenue in Small Molecular API Business (2015-2020)
13.6.5 Glaxosmithkline Plc. Recent Development
13.7 Lonza
13.7.1 Lonza Company Details
13.7.2 Lonza Business Overview
13.7.3 Lonza Small Molecular API Introduction
13.7.4 Lonza Revenue in Small Molecular API Business (2015-2020)
13.7.5 Lonza Recent Development
13.8 Merck Sharp & Dohme Corp.
13.8.1 Merck Sharp & Dohme Corp. Company Details
13.8.2 Merck Sharp & Dohme Corp. Business Overview
13.8.3 Merck Sharp & Dohme Corp. Small Molecular API Introduction
13.8.4 Merck Sharp & Dohme Corp. Revenue in Small Molecular API Business (2015-2020)
13.8.5 Merck Sharp & Dohme Corp. Recent Development
13.9 Mylan N.V.
13.9.1 Mylan N.V. Company Details
13.9.2 Mylan N.V. Business Overview
13.9.3 Mylan N.V. Small Molecular API Introduction
13.9.4 Mylan N.V. Revenue in Small Molecular API Business (2015-2020)
13.9.5 Mylan N.V. Recent Development
13.10 Novartis AG
13.10.1 Novartis AG Company Details
13.10.2 Novartis AG Business Overview
13.10.3 Novartis AG Small Molecular API Introduction
13.10.4 Novartis AG Revenue in Small Molecular API Business (2015-2020)
13.10.5 Novartis AG Recent Development
13.11 Pfizer Inc.
10.11.1 Pfizer Inc. Company Details
10.11.2 Pfizer Inc. Business Overview
10.11.3 Pfizer Inc. Small Molecular API Introduction
10.11.4 Pfizer Inc. Revenue in Small Molecular API Business (2015-2020)
10.11.5 Pfizer Inc. Recent Development
13.12 Siegfried AG
10.12.1 Siegfried AG Company Details
10.12.2 Siegfried AG Business Overview
10.12.3 Siegfried AG Small Molecular API Introduction
10.12.4 Siegfried AG Revenue in Small Molecular API Business (2015-2020)
10.12.5 Siegfried AG Recent Development
13.13 Sun Pharmaceutical Industries Ltd.
10.13.1 Sun Pharmaceutical Industries Ltd. Company Details
10.13.2 Sun Pharmaceutical Industries Ltd. Business Overview
10.13.3 Sun Pharmaceutical Industries Ltd. Small Molecular API Introduction
10.13.4 Sun Pharmaceutical Industries Ltd. Revenue in Small Molecular API Business (2015-2020)
10.13.5 Sun Pharmaceutical Industries Ltd. Recent Development
13.14 Teva Pharmaceutical Industries Ltd.
10.14.1 Teva Pharmaceutical Industries Ltd. Company Details
10.14.2 Teva Pharmaceutical Industries Ltd. Business Overview
10.14.3 Teva Pharmaceutical Industries Ltd. Small Molecular API Introduction
10.14.4 Teva Pharmaceutical Industries Ltd. Revenue in Small Molecular API Business (2015-2020)
10.14.5 Teva Pharmaceutical Industries Ltd. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Small Molecular API Key Market Segments
Table 2. Key Players Covered: Ranking by Small Molecular API Revenue
Table 3. Ranking of Global Top Small Molecular API Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Small Molecular API Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthetic/Chemical API
Table 6. Key Players of Biological API
Table 7. Global Small Molecular API Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Small Molecular API Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Small Molecular API Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Small Molecular API Market Share by Regions (2015-2020)
Table 11. Global Small Molecular API Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Small Molecular API Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Small Molecular API Market Growth Strategy
Table 17. Main Points Interviewed from Key Small Molecular API Players
Table 18. Global Small Molecular API Revenue by Players (2015-2020) (Million US$)
Table 19. Global Small Molecular API Market Share by Players (2015-2020)
Table 20. Global Top Small Molecular API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecular API as of 2019)
Table 21. Global Small Molecular API by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Small Molecular API Product Solution and Service
Table 24. Date of Enter into Small Molecular API Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 27. Global Small Molecular API Market Size Share by Type (2015-2020)
Table 28. Global Small Molecular API Revenue Market Share by Type (2021-2026)
Table 29. Global Small Molecular API Market Size Share by Application (2015-2020)
Table 30. Global Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 31. Global Small Molecular API Market Size Share by Application (2021-2026)
Table 32. North America Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Small Molecular API Market Share (2019-2020)
Table 34. North America Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 35. North America Small Molecular API Market Share by Type (2015-2020)
Table 36. North America Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 37. North America Small Molecular API Market Share by Application (2015-2020)
Table 38. Europe Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Small Molecular API Market Share (2019-2020)
Table 40. Europe Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Small Molecular API Market Share by Type (2015-2020)
Table 42. Europe Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Small Molecular API Market Share by Application (2015-2020)
Table 44. China Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 45. China Key Players Small Molecular API Market Share (2019-2020)
Table 46. China Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 47. China Small Molecular API Market Share by Type (2015-2020)
Table 48. China Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 49. China Small Molecular API Market Share by Application (2015-2020)
Table 50. Japan Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Small Molecular API Market Share (2019-2020)
Table 52. Japan Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Small Molecular API Market Share by Type (2015-2020)
Table 54. Japan Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Small Molecular API Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Small Molecular API Market Share (2019-2020)
Table 58. Southeast Asia Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Small Molecular API Market Share by Type (2015-2020)
Table 60. Southeast Asia Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Small Molecular API Market Share by Application (2015-2020)
Table 62. India Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 63. India Key Players Small Molecular API Market Share (2019-2020)
Table 64. India Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 65. India Small Molecular API Market Share by Type (2015-2020)
Table 66. India Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 67. India Small Molecular API Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Small Molecular API Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Small Molecular API Market Share (2019-2020)
Table 70. Central & South America Small Molecular API Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Small Molecular API Market Share by Type (2015-2020)
Table 72. Central & South America Small Molecular API Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Small Molecular API Market Share by Application (2015-2020)
Table 74. Albemarle Corporation Company Details
Table 75. Albemarle Corporation Business Overview
Table 76. Albemarle Corporation Product
Table 77. Albemarle Corporation Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 78. Albemarle Corporation Recent Development
Table 79. Allergan Plc. Company Details
Table 80. Allergan Plc. Business Overview
Table 81. Allergan Plc. Product
Table 82. Allergan Plc. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 83. Allergan Plc. Recent Development
Table 84. Aurobindo Pharma Company Details
Table 85. Aurobindo Pharma Business Overview
Table 86. Aurobindo Pharma Product
Table 87. Aurobindo Pharma Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 88. Aurobindo Pharma Recent Development
Table 89. Cambrex Corporation Company Details
Table 90. Cambrex Corporation Business Overview
Table 91. Cambrex Corporation Product
Table 92. Cambrex Corporation Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 93. Cambrex Corporation Recent Development
Table 94. Dr. Reddy’s Laboratories Ltd. Company Details
Table 95. Dr. Reddy’s Laboratories Ltd. Business Overview
Table 96. Dr. Reddy’s Laboratories Ltd. Product
Table 97. Dr. Reddy’s Laboratories Ltd. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 98. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 99. Glaxosmithkline Plc. Company Details
Table 100. Glaxosmithkline Plc. Business Overview
Table 101. Glaxosmithkline Plc. Product
Table 102. Glaxosmithkline Plc. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 103. Glaxosmithkline Plc. Recent Development
Table 104. Lonza Company Details
Table 105. Lonza Business Overview
Table 106. Lonza Product
Table 107. Lonza Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 108. Lonza Recent Development
Table 109. Merck Sharp & Dohme Corp. Business Overview
Table 110. Merck Sharp & Dohme Corp. Product
Table 111. Merck Sharp & Dohme Corp. Company Details
Table 112. Merck Sharp & Dohme Corp. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 113. Merck Sharp & Dohme Corp. Recent Development
Table 114. Mylan N.V. Company Details
Table 115. Mylan N.V. Business Overview
Table 116. Mylan N.V. Product
Table 117. Mylan N.V. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 118. Mylan N.V. Recent Development
Table 119. Novartis AG Company Details
Table 120. Novartis AG Business Overview
Table 121. Novartis AG Product
Table 122. Novartis AG Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 123. Novartis AG Recent Development
Table 124. Pfizer Inc. Company Details
Table 125. Pfizer Inc. Business Overview
Table 126. Pfizer Inc. Product
Table 127. Pfizer Inc. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 128. Pfizer Inc. Recent Development
Table 129. Siegfried AG Company Details
Table 130. Siegfried AG Business Overview
Table 131. Siegfried AG Product
Table 132. Siegfried AG Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 133. Siegfried AG Recent Development
Table 134. Sun Pharmaceutical Industries Ltd. Company Details
Table 135. Sun Pharmaceutical Industries Ltd. Business Overview
Table 136. Sun Pharmaceutical Industries Ltd. Product
Table 137. Sun Pharmaceutical Industries Ltd. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 138. Sun Pharmaceutical Industries Ltd. Recent Development
Table 139. Teva Pharmaceutical Industries Ltd. Company Details
Table 140. Teva Pharmaceutical Industries Ltd. Business Overview
Table 141. Teva Pharmaceutical Industries Ltd. Product
Table 142. Teva Pharmaceutical Industries Ltd. Revenue in Small Molecular API Business (2015-2020) (Million US$)
Table 143. Teva Pharmaceutical Industries Ltd. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecular API Market Share by Type: 2020 VS 2026
Figure 2. Synthetic/Chemical API Features
Figure 3. Biological API Features
Figure 4. Global Small Molecular API Market Share by Application: 2020 VS 2026
Figure 5. Cardiovascular Case Studies
Figure 6. Oncology Case Studies
Figure 7. Diabetes Case Studies
Figure 8. Immunological Disorders Case Studies
Figure 9. Others Case Studies
Figure 10. Small Molecular API Report Years Considered
Figure 11. Global Small Molecular API Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Small Molecular API Market Share by Regions: 2020 VS 2026
Figure 13. Global Small Molecular API Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Small Molecular API Market Share by Players in 2019
Figure 16. Global Top Small Molecular API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecular API as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Small Molecular API Revenue in 2019
Figure 18. North America Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Small Molecular API Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
腫瘍学分子診断の世界市場（～2026年） Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oncology Based Molecular Diagnostic Scope a…- 分子イメージング剤の世界市場（～2026年） Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratificati…
- 小分子創薬の世界市場（～2026年） Market Analysis and Insights: Global Small-Molecule Drug Discovery Market The global Small-Molecule Drug Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small-Molecule Drug Discovery Scope and Market Size Sma…
- POC分子診断の世界市場（～2026年） Market Analysis and Insights: Global POC Molecular Diagnostics Market The global POC Molecular Diagnostics market size is projected to reach US$ 654.1 million by 2026, from US$ 580.4 million in 2020, at a CAGR of 11.8%% during 2021-2026. Global POC Molecular Diagnostics Scope and Market Size POC Mol…
- 小細胞肺がん治療薬の世界市場（～2026年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…